Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Epigenetics
>>
Phase 1
«
1
2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
IMP7068
/ IMPACT Therap
IPN60210
/ Ipsen
ISM3412
/ Insilico Medicine
KT-413
/ Kymera Therap
KTX-1001
/ K36 Therap
KY100001
/ KPC Pharma
MAK683
/ Novartis
MPT0E028
/ Anbogen Therap, Formosa Labs
NEO2734
/ Epigenetix
NX-2127
/ Nurix Therap
ORIC-944
/ ORIC Pharma
PF-06939999
/ Pfizer
PRT3789
/ Prelude Therap
PRT543
/ Prelude Therap
PRT811
/ Prelude Therap
PX-478
/ Pfizer
RG6457
/ Roche, Bayer
S95035
/ Servier
SH1573
/ Nanjing Sanhome Pharma
SH3765
/ Nanjing Sanhome Pharma
SIM0272
/ Simcere
SY-4835
/ Shouyao Holdings
SYHA1801
/ CSPC Pharma
SYHA1807
/ WuXi AppTec, CSPC Pharma
SYHX2001
/ CSPC Pharma
TACH101
/ Tachyon
TAS1440
/ Otsuka
TQB3455
/ Sino Biopharm
TQB3820
/ Sino Biopharm
ZEN003365
/ Zenith Capital Corp
camptothecin/podophyllotoxin
(NEV-801) / Neovia Oncology
citatuzumab bogatox
(VB6-845) / CARISMA Therap
deuterated S-avadomide
(SP-3164) / Salarius
everolimus
(SVG101) / SoVarGen
ivaltinostat oral
(CG-750) / CG Invites
long-acting azacitidine
(NEX-18a) / Nanexa AB
misetionamide
(GP-2250) / Panavance Therap
onametostat
(JNJ-64619178) / J&J
pocenbrodib
(P-300) / Pathos
solitomab
(AMG 110) / Amgen
spiruchostatin A
(OBP-801) / Oncolys BioPharma
trichostatin A
(VTR-297) / Vanda
«
1
2
